Agency Forms Undergoing Paperwork Reduction Act Review
Published Date: 6/26/2026
Notice
Summary
The CDC is asking for public feedback on a new form they want to use for health surveys. They’re making sure the form is useful, clear, and easy to fill out, and they want to keep the time and cost low for everyone involved. You’ve got 30 days to share your thoughts before the government gives the final thumbs-up!
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22881, Proposed Data Collection Submitted for Public Comment and Recommendations
The CDC wants your thoughts on a new survey about how they’re fighting opioid overdoses in 90 places across the country. This helps them improve their work and reduce paperwork for everyone. If you want to share your ideas, you’ve got until January 11, 2027, to speak up—no money changes, just smarter info gathering!
2026-22775, Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health
The Advisory Board on Radiation and Worker Health is holding a virtual meeting on December 2, 2026, to discuss important health and safety issues for workers exposed to radiation. Anyone interested can join online or by phone, and the public can share their thoughts by November 19. This meeting helps shape policies that protect workers and could impact compensation programs.
2026-22819, Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for public feedback on their National Survey of Syringe Services Programs to make sure the info they collect is useful and not too much work. They’re giving everyone 30 more days to share thoughts before final approval. This affects people running syringe programs and aims to keep data collection smart and efficient without extra costs or hassle.
2026-22330, Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on a new form they want to use for testing health info collection. If you or your group might fill out these forms, now’s the time to speak up! You’ve got 30 days to share your ideas, and this helps keep paperwork easy and useful without wasting time or money.
2026-22329, Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for public feedback on a new form for the Fragile X Online Registry to make sure it’s useful and not too much work for people to fill out. If you have thoughts on how to improve it or reduce hassle, now’s your chance to speak up within 30 days. This helps keep data collection smart and efficient without costing extra time or money.
2026-22211, Notice of Amended Order Requirement for Attestation by All Persons Arriving in the United States From Any Foreign Country Via Transportation by Aircraft and Controlled Free Pratique for Airlines and Other Aircraft Operators Confirming That Such Persons Have Not Been in the Democratic Republic of the Congo in the Past 21 Days
Starting November 3, 2026, anyone flying to the U.S. from another country must sign a statement saying they haven’t been in the Democratic Republic of the Congo in the last 21 days. This rule applies to passengers and crew and will stay in effect until December 18, 2026. Airlines must check these attestations before boarding, helping keep everyone safe without extra costs for travelers.
Previous / Next Documents
Previous: 2026-12957, Sunshine Act Meetings; Correction
The Postal Service fixed some missing details about their Board of Governors meeting on May 8, 2026. They clarified the exact times, location, and what topics will be covered during the closed morning session and the open afternoon session. This update helps everyone stay in the loop with no extra costs or delays.
Next: 2026-12959, Determination That Prednisolone Tablet, 5 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that the 5 mg prednisolone tablet wasn’t taken off the market because of safety or effectiveness problems. This means generic drug makers can keep getting approval to sell their versions of this medicine, as long as they follow the rules. Patients and pharmacies can expect continued access to affordable generics without any interruptions or extra costs.